(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Mummified cheetahs found in Saudi caves shed light on lost populations - 2Netflix’s Price Hikes Just Got Rejected by an Italian Court. Here’s Why It Matters Everywhere
- 3NASA’s Artemis II launch leaves Americans in awe: ‘We’re going to the frickin’ moon!’
- 412 Once-In-A-Lifetime Travel Experiences To Add to Your Bucket List
- 5Satellite data reveals a huge solar storm in 2024 shrank Earth's protective plasma shield
- Flu cases are spiking earlier than usual. What you need to know.
- Lucky airplane passengers capture NASA's Artemis 2 moon launch from the sky
- Vote In favor of Your #1 Electric Vehicles
- Israel’s mixed messaging on Christmas draws controversy
- Under pressure at home, Belgium's leader treads a tight rope with EU partners over funds for Ukraine
- Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
- The wolf supermoon will kick off 2026 with a celestial bang. Here's when and how to see it.
- Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract
- Excited visitors for NASA's moon launch jockey for prime views
